Loading…
Beta Bionics, Inc. is projected to rise to $26.88 by 2027, a +58% move from its current price of $17.03. BBNX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $16.42 | $17.05 | $17.71 | +0.13% |
| Jul 15 | $16.19 | $17.08 | $18.01 | +0.27% |
| Jul 16 | $16.02 | $17.10 | $18.25 | +0.40% |
| Jul 17 | $15.88 | $17.12 | $18.46 | +0.54% |
| Jul 18 | $15.76 | $17.14 | $18.65 | +0.67% |
| Jul 19 | $15.66 | $17.17 | $18.83 | +0.81% |
| Jul 20 | $15.56 | $17.19 | $18.99 | +0.95% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $15.56 | $17.19 | $18.99 | +0.95% |
| Week 2 | $15.08 | $17.35 | $19.98 | +1.90% |
| Week 3 | $14.74 | $17.52 | $20.81 | +2.86% |
| Week 4 | $14.49 | $17.68 | $21.58 | +3.84% |
| Week 5 | $14.29 | $17.85 | $22.30 | +4.82% |
| Week 6 | $14.12 | $18.02 | $22.99 | +5.81% |
| Week 7 | $13.98 | $18.19 | $23.67 | +6.81% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes.
It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system.
The company was incorporated in 2015 and is headquartered in Irvine, California.
BBNX is a healthcare stock with current price $17.03, a market cap of $758.89M, and a market position that places it at rank 2725. The current price and near-term metrics reflect a stock in a niche medical devices segment.
A major floor 48.0% below — a decisive break under it would weaken the trend.
The nearest floor, 28.9% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 19.3% above — clearing it would confirm fresh momentum.
Key BBNX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BBNX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $16.67 | Buy | $16.66 | Buy |
| MA 10 | $16.63 | Buy | $16.33 | Buy |
| MA 20 | $15.45 | Buy | $15.52 | Buy |
| MA 50 | $12.90 | Buy | $13.99 | Buy |
| MA 100 | $12.14 | Buy | $14.14 | Buy |
| MA 200 | $17.96 | Sell | $15.75 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.13 | Neutral |
| Stoch RSI (14) | 43.61 | Neutral |
| CCI (20) | 85.78 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | 24.58 | Buy |
| Bollinger %B (20,2) | 0.80 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 1.22 | Buy |
| Awesome (5,34) | 2.36 | Buy |
| Ultimate (7,14,28) | 70.65 | Sell |
| Momentum (10) | 1.12 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 16.60 | Buy |
| ADX (14) | 30.32 | Buy |
| ATR (14) | 0.51 | Info |
Technical sentiment is BULLISH with an RSI(14) of 70. The SMA50 is $12.90 and the SMA200 is $17.96, providing a near-term frame where price action sits around key moving averages. The stock shows support at $12.10 and a resistance at $17.03, with a 30-day range from $13.29 to $21.82. Annualized volatility is 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.86 | $17.03 | $29.48 | 0% | Neutral | |
| $20.62 | $26.88 | $37.50 | +58% | Bullish | |
| $23.57 | $32.00 | $46.88 | +88% | Bullish | |
| $24.73 | $34.73 | $52.83 | +104% | Bullish | |
| $24.63 | $35.66 | $55.99 | +109% | Bullish | |
| $27.50 | $40.94 | $66.05 | +140% | Bullish | |
| $30.15 | $46.09 | $76.19 | +171% | Bullish | |
| $37.97 | $59.50 | $100.55 | +249% | Bullish | |
| $44.23 | $70.98 | $122.38 | +317% | Bullish | |
| $43.34 | $71.17 | $125.01 | +318% | Bullish | |
| $63.41 | $115.84 | $219.80 | +580% | Bullish | |
| $96.98 | $215.26 | $456.09 | +11.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $8.86 | $17.03 | $21.07 | +0.00% |
| August 2026 | $15.76 | $18.80 | $23.16 | +10.38% |
| September 2026 | $15.98 | $19.25 | $24.09 | +2.42% |
| October 2026 | $16.21 | $19.69 | $24.95 | +2.27% |
| November 2026 | $17.46 | $21.36 | $27.36 | +8.51% |
| December 2026 | $18.50 | $22.79 | $29.48 | +6.69% |
Click any year to see its month-by-month BBNX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Beta Bionics, Inc.'s 2026 outlook centres on $17.03, within a $8.86 to $29.48 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, BBNX could reach as high as $37.50, with a base case around $26.88 and support toward $20.62 — roughly +58% from $17.03. Momentum favours further upside here.
Expect BBNX to range from $23.57 to $46.88 through 2028. The $32.00 average target implies a +88% move from current prices. That is up +19% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The BBNX price prediction for 2029 points to an average of $34.73 (low $24.73, high $52.83) — a potential gain of +104% on today's $17.03. Momentum favours further upside here.
In 2030, BBNX is projected to trade between $24.63 and $55.99, averaging $35.66 — a potential gain of +109% from today's $17.03. That is up +3% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Beta Bionics, Inc.'s 2031 outlook centres on $40.94, within a $27.50 to $66.05 range. That is up +15% on the projected 2030 average. That marks a +140% change versus current levels. Momentum favours further upside here.
By 2032, BBNX could reach as high as $76.19, with a base case around $46.09 and support toward $30.15 — roughly +171% from $17.03. Buyers look set to stay in control over this stretch.
Expect BBNX to range from $37.97 to $100.55 through 2033. The $59.50 average target implies a +249% move from current prices. That is up +29% on the projected 2032 average. Momentum favours further upside here.
The BBNX price prediction for 2034 points to an average of $70.98 (low $44.23, high $122.38) — a potential gain of +317% on today's $17.03. Buyers look set to stay in control over this stretch.
In 2035, BBNX is projected to trade between $43.34 and $125.01, averaging $71.17 — a potential gain of +318% from today's $17.03. That is up 0% on the projected 2034 average. Momentum favours further upside here.
Beta Bionics, Inc.'s 2040 outlook centres on $115.84, within a $63.41 to $219.80 range. That is up +63% on the projected 2035 average. That marks a +580% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, BBNX could reach as high as $456.09, with a base case around $215.26 and support toward $96.98 — roughly +11.6x from $17.03. Momentum favours further upside here.
Investing $1,000 in BBNX today (≈ 58.719906 BBNX) could be worth
$12,640.09
+$11,640.09 (+1164%) by 2050 · US Dollar
Based on the average projected BBNX price of $215.26 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BBNXwould be worth at today's price.
$1,000 invested in BBNX on Jul 10, 2025 (≈ 73.74631 BBNX) would be worth
$1,255.9
+$255.9 (+25.6%) today · 1.26× · US Dollar
Based on a BBNX entry price of $13.56 vs. today's $17.03.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $16.76 | $1,016.11 | +1.6% |
| 1 month ago | $13.72 | $1,241.25 | +24.1% |
| 3 months ago | $8.86 | $1,922.12 | +92.2% |
| 6 months ago | $17.65 | $964.87 | -3.5% |
| 1 year ago | $13.56 | $1,255.9 | +25.6% |
| All time (1.4y) ago | $23.63 | $720.69 | -27.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BBNX forecast.
Our base-case forecast reaches $34.00 around 2029.
Implied market cap at $34.00: $1.52B
The multi-year forecast shows sustained upside with 2026’s average price at $17.03 (min $8.86, max $29.51) and ROI 0, indicating neutral sentiment. From 2027 onward, values rise with 2027 Avg $26.86, 2028 Avg $32.04, 2029 Avg $34.74, and 2030 Avg $35.63 with ROI 109.2 and bullish sentiment. Looking further, 2031 Avg $41.00, 2032 Avg $46.09, 2033 Avg $59.50, 2034 Avg $71.11, and 2035 Avg $71.09, all with bullish sentiment.
The forecast extends to 2040 Avg $116.03 (ROI 581.3) and 2050 Avg $215.17 (ROI 1163.5), both labeled bullish. These projections are estimates and may not reflect actual results.
Tap a question to reveal the answer.
2030 Avg $35.63, Min $24.61, Max $55.94, ROI 109.2, sentiment BULLISH.
Forecasts show bullish sentiment in multiple years (e.g., 2027 Avg $26.86, 2030 Avg $35.63, 2040 Avg $116.03, 2050 Avg $215.17) with rising averages, while 2026 is neutral with Avg $17.03 and ROI 0.
Yes—the 2030 maximum in the forecast is $55.94.
Current price $17.03; Market cap $758.89M.
2050 Avg $215.17, Min $96.94, Max $455.91, ROI 1163.5, sentiment BULLISH.
Beta Bionics, Inc. Community Discussion
0Share your Beta Bionics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.